HopeStage
Back to all studies
CompletedNCT04569357

Prospekta for ADHD symptoms in children

About this titleRead the official source — NCT04569357

Researchers compared Prospekta and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.

Medication studyAges 7–12Russia
The study in practice

Understand this study

What did researchers investigate?

Researchers compared Prospekta and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.

Who was this study for?

This study was for people with ADHD. Listed age limits: 7 years to 12 years. Other eligibility criteria applied.

Listed locations
Bryansk and 30 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: November 20, 2020
Recruitment status
Completed
Enrollment listed in the registry
363
Sponsor
Materia Medica Holding
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Russia
Age range
From 7 Years to 12 Years
Official registry ID
NCT04569357
Official title
Show the full official title

Multicenter Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bryansk, Russia · Chelyabinsk, Russia · Engel's, Russia

17 more locations
  • Kazan', Russia
  • Krasnodar, Russia
  • Moscow, Russia
  • Nizhny Novgorod, Russia
  • Orenburg, Russia
  • Perm, Russia
  • Rostov-on-Don, Russia
  • Ryazan, Russia
  • Saint Petersburg, Russia
  • Saratov, Russia
  • Smolensk, Russia
  • Stavropol, Russia
  • Tver', Russia
  • Ulyanovsk, Russia
  • Yaroslavl, Russia
  • Yekaterinburg, Russia
  • Russia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared Prospekta and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.

Who is behind this study?

The study sponsor is Materia Medica Holding.

Did this study involve medication?

Yes. The study involved medication, including Prospekta and Placebo.

Who was this study for?

This study was for people with ADHD. Listed age limits: 7 years to 12 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies